Vericel Corporation is a USA-based biopharmaceutical company that specializes in creating cellular therapies for sports medicine and severe burn care markets. They are the manufacturers and distributors of MACI, a product designed for the repair of knee cartilage defects, and Epicel, a permanent skin replacement device for patients with deep-dermal or full-thickness burns. Their current preapproval stage product is NexoBrid, which aids in eschar removal for adults with thermal burns.